Tyrosine-protein kinase BTK
| GO Term | Evidence Code | Reference |
|---|---|---|
| neutrophil homeostasis | ||
| neutrophil homeostasis | ||
| positive regulation of type III hypersensitivity | ||
| positive regulation of type III hypersensitivity | ||
| positive regulation of type I hypersensitivity |
| GO Term | Evidence Code | Reference |
|---|---|---|
| protein tyrosine kinase activity | ||
| protein tyrosine kinase activity | ||
| protein tyrosine kinase activity | ||
| protein tyrosine kinase activity | ||
| non-membrane spanning protein tyrosine kinase activity |
| Pathway Name | Organism |
|---|---|
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | Mus musculus |
| DAP12 signaling | Mus musculus |
| FCERI mediated Ca+2 mobilization | Mus musculus |
| G alpha (12/13) signalling events | Mus musculus |
| G alpha (q) signalling events | Mus musculus |
| G beta:gamma signalling through BTK | Mus musculus |
| RHO GTPases Activate WASPs and WAVEs | Mus musculus |
| Regulation of actin dynamics for phagocytic cup formation | Mus musculus |
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:14179 | X-linked agammaglobulinemia |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026